NCT06723405CompletedPhase 2
Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo-controlled, Proof-of-concept Study of EVO301 in Adults With Atopic Dermatitis
Source: ClinicalTrials.gov · Last updated 4 Dec 2025
Brief summary (registry, in English)
This is a Phase 2a efficacy and safety study of EVO301 for the treatment of adults with atopic dermatitis.
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 71 (actual)
- First submitted
- 4 Dec 2024
- Start date
- 13 Feb 2025
- Primary completion date
- 17 Nov 2025
- Lead sponsor
- Evommune, Inc.
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT06723405
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 71
- From 13 Feb 2025 to the primary completion date, 17 Nov 2025
- 12 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of biologic therapy within 12 weeks
Other illness
- Skin condition that could interfere with study assessments
Other
- Significant AD flare with 4 weeks
- Regular use of tanning booth within 4 weeks
Who the study is looking for
- Males or non-pregnant, non-lactating females, age 18 years or older
- Chronic atopic dermatitis for at least 6 months
- BSA of AD involvement of at least 10%
- EASI score of at least 16.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (12)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cornerstone Dermatology Coordinator of this site? Confirm its status | Coorparoo | Australia | Unknown status |
| Momentum Clinical Research Darlinghurst Coordinator of this site? Confirm its status | Darlinghurst | Australia | Unknown status |
| Pacific Clinical Research Network (PCRN) Auckland Coordinator of this site? Confirm its status | Auckland | New Zealand | Unknown status |
| Optimal Clinical Trials Coordinator of this site? Confirm its status | Auckland | New Zealand | Unknown status |
| Optimal Clinical Trials (North) Coordinator of this site? Confirm its status | Auckland | New Zealand | Unknown status |
| Pacific Clinical Research Network (PCRN) - Christchurch Coordinator of this site? Confirm its status | Christchurch | New Zealand | Unknown status |
| Momentum Clinical Research, Dunedin Coordinator of this site? Confirm its status | Dunedin | New Zealand | Unknown status |
| Clinical Trials New Zealand Ltd Coordinator of this site? Confirm its status | Hamilton | New Zealand | Unknown status |
| Momentum Clinical Research Lower Hutt Coordinator of this site? Confirm its status | Hutt Central | New Zealand | Unknown status |
| Pacific Clinical Research Network (PCRN) - Tasman Coordinator of this site? Confirm its status | Nelson | New Zealand | Unknown status |
| Momentum Clinical Research Kapiti Coordinator of this site? Confirm its status | Paraparaumu | New Zealand | Unknown status |
| Momentum Clinical Research - Pukekohe Coordinator of this site? Confirm its status | Pukekohe | New Zealand | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.